Relative effects of heavy alcohol use and Hepatitis C in decompensated chronic liver disease in a hospital inpatient population

References

• World Health Organization. Global status report on alcohol and health. Geneva, Switzerland: World Health Organization; 2011
   Google Scholar
• Wilkins T, Malcolm JK, Raina D, Schade RR. Hepatitis C: diagnosis and treatment. Am Fam Physician 2010;81:1351–1357
   PubMed Web of Science ®Google Scholar
• Custer B, Sullivan SD, Hazlet TK, Iloeje U, Veenstra DL, Kowdley KV. Global epidemiology of hepatitis B virus. J Clin Gastroenterol. 2004;38:S158–168
   PubMed Web of Science ®Google Scholar
• Kumar M, Herrera JL. Importance of hepatitis vaccination in patients with chronic liver disease. South Med J 2010;103:1223–1231
   Google Scholar
• Leise MD, Talwalkar JA. Immunizations in chronic liver disease: what should be done and what is the evidence. Curr Gastroenterol Rep 2013;15:300
   Google Scholar
• Aspinall EJ, Hawkins G, Fraser A, Hutchinson SJ, Goldberg D. Hepatitis B prevention, diagnosis, treatment and care: a review. Occup Med (Lond) 2011;61:531–540
   PubMed Web of Science ®Google Scholar
• Prevention. CfDCa. Hepatitis C Surveillance 2010. Atlanta: U.S. Department of Health and Human Services
   Google Scholar
• Liang TJ, Rehermann B, Seeff LB, Hoofnagle JH. Pathogenesis, natural history, treatment, and prevention of hepatitis C. Ann Intern Med 2000;132:296–305
   PubMedGoogle Scholar
• Asrani SK, Kamath PS. Natural history of cirrhosis. Curr Gastroenterol Rep 2013;15:308
   PubMedGoogle Scholar
• Maasoumy B, Wedemeyer H. Natural history of acute and chronic hepatitis C. Best Pract Res Clin Gastroenterol 2012;26:401–412
   PubMed Web of Science ®Google Scholar
• Schwartz JM, Reinus JF. Prevalence and natural history of alcoholic liver disease. Clin Liver Dis 2012;16:659–666
   Google Scholar
• Ryder SD, Irving WL, Jones DA, Neal KR, Underwood JC. Progression of hepatic fibrosis in patients with hepatitis C: a prospective repeat liver biopsy study. Gut 2004;53:451–455
   PubMed Web of Science ®Google Scholar
• Freeman AJ, Dore GJ, Law MG, Thorpe M, Von Overbeck J, Lloyd AR, et al. Estimating progression to cirrhosis in chronic hepatitis C virus infection. Hepatology 2001;34:809–816
   PubMed Web of Science ®Google Scholar
• Lim JK. Natural history of hepatitis C infection: a concise review. Yale J Biol Med 2001;74:229–237
   Google Scholar
• Dore GJ, Freeman AJ, Law M, Kaldor JM. Is severe liver disease a common outcome for people with chronic hepatitis C? J Gastroenterol Hepatol 2002;17:423–430
   PubMed Web of Science ®Google Scholar
• Hutchinson SJ, Bird SM, Goldberg DJ. Influence of alcohol on the progression of hepatitis C virus infection: a meta-analysis. Clin Gastroenterol Hepatol 2005;3:1150–1159
   PubMed Web of Science ®Google Scholar
• Frieden TR, Ozick L, McCord C, Nainan OV, Workman S, Comer G, et al. Chronic liver disease in central Harlem: the role of alcohol and viral hepatitis. Hepatology 1999;29:883–888
   Google Scholar
• Bhattacharya R, Shuhart MC. Hepatitis C and alcohol: interactions, outcomes, and implications. J Clin Gastroenterol 2003;36:242–252
   PubMed Web of Science ®Google Scholar
• Grewal P, Viswanathen VA. Liver cancer and alcohol. Clin Liver Dis 2012;16:839–850
   PubMed Web of Science ®Google Scholar
• Berman K, Tandra S, Vuppalanchi R, Ghabril M, Sandrasegaran K, Nguyen J, et al. Hepatic and extrahepatic cancer in cirrhosis: a longitudinal cohort study. Am J Gastroenterol 2011;106:899–906
   Google Scholar
• Donato F, Tagger A, Gelatti U, Parrinello G, Boffetta P, Albertini A, et al. Alcohol and hepatocellular carcinoma: the effect of lifetime intake and hepatitis virus infections in men and women. Am J Epidemiol 2002;155:323–331
   PubMed Web of Science ®Google Scholar
• Davis GL, Alter MJ, El-Serag H, Poynard T, Jennings LW. Aging of hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression. Gastroenterology 2010;138:513–521, 521 e1–6
   PubMed Web of Science ®Google Scholar
• Klevens RM, Hu DJ, Jiles R, Holmberg SD. Evolving epidemiology of hepatitis C virus in the United States. Clin Infect Dis 2012:S3–9
   Google Scholar
• Gomez EV, Rodriguez YS, Bertot LC, Gonzalez AT, Perez YM, Soler EA, et al. The natural history of compensated HCV-related cirrhosis: a prospective long-term study. J Hepatol 2013;58:434–444
   Google Scholar
• Gordon SC, Pockros PJ, Terrault NA, Hoop RS, Buikema A, Nerenz D, et al. Impact of disease severity on healthcare costs in patients with chronic hepatitis C (CHC) virus infection. Hepatology 2012;56:1651–1660
   PubMed Web of Science ®Google Scholar
• McAdam-Marx C, McGarry LJ, Hane CA, Biskupiak J, Deniz B, Brixner DI. All-cause and incremental per patient per year cost associated with chronic hepatitis C virus and associated liver complications in the United States: a managed care perspective. J Manag Care Pharm. 2011;17:531–546
   PubMed Web of Science ®Google Scholar
• McCombs JS, Yuan Y, Shin J, Saab S. Economic burden associated with patients diagnosed with hepatitis C. Clin Ther 2011;33:1268–1280
   PubMed Web of Science ®Google Scholar
• D’Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol 2006;44:217–231
   PubMed Web of Science ®Google Scholar
• Asrani S, Kamath P. Natural history of cirrhosis. Curr Gastroenterol Rep 2013;15:1–6
   Google Scholar
• Fleming KM, Aithal GP, Card TR, West J. The rate of decompensation and clinical progression of disease in people with cirrhosis: a cohort study. Aliment Pharmacol Ther 2010;32:1343–1350
   PubMed Web of Science ®Google Scholar
• Schuppan D, Afdhal NH. Liver cirrhosis. Lancet 2008;371:838–851
   PubMed Web of Science ®Google Scholar
• Becker U, Deis A, Sorensen TI, Gronbaek M, Borch-Johnsen K, Muller CF, et al. Prediction of risk of liver disease by alcohol intake, sex, and age: a prospective population study. Hepatology 1996;23:1025–1029
   PubMed Web of Science ®Google Scholar
• Kamper-Jorgensen M, Gronbaek M, Tolstrup J, Becker U. Alcohol and cirrhosis: dose-response or threshold effect? J Hepatol 2004;41:25–30
   PubMed Web of Science ®Google Scholar
• Gitto S, Micco L, Conti F, Andreone P, Bernardi M. Alcohol and viral hepatitis: a mini-review. Dig Liver Dis 2009;41:67–70
   Google Scholar
• Gramenzi A, Caputo F, Biselli M, Kuria F, Loggi E, Andreone P, et al. Review article: alcoholic liver disease – pathophysiological aspects and risk factors. Aliment Pharmacol Ther 2006;24:1151–1161
   PubMed Web of Science ®Google Scholar
• Bellentani S, Saccoccio G, Costa G, Tiribelli C, Manenti F, Sodde M, et al. Drinking habits as cofactors of risk for alcohol induced liver damage. The Dionysos Study Group. Gut 1997;41:845–850
   PubMed Web of Science ®Google Scholar
• Day CP. Who gets alcoholic liver disease: nature or nurture? J R Coll Physicians Lond 2000;34:557–562
   PubMedGoogle Scholar
• Mandayam S, Jamal MM, Morgan TR. Epidemiology of alcoholic liver disease. Semin Liver Dis 2004;24:217–232
   PubMed Web of Science ®Google Scholar
• Lu XL, Luo JY, Tao M, Gen Y, Zhao P, Zhao HL, et al. Risk factors for alcoholic liver disease in China. World J Gastroenterol 2004;10:2423–2426
   PubMed Web of Science ®Google Scholar
• Stokkeland K, Hilm G, Spak F, Franck J, Hultcrantz R. Different drinking patterns for women and men with alcohol dependence with and without alcoholic cirrhosis. Alcohol Alcohol 2008;43:39–45
   PubMed Web of Science ®Google Scholar
• Innes HA, Hutchinson SJ, Barclay S, Cadzow E, Dillon JF, Fraser A, et al. Quantifying the fraction of cirrhosis attributable to alcohol among chronic hepatitis C virus patients: implications for treatment cost-effectiveness. Hepatology 2013;57:451–460
   PubMed Web of Science ®Google Scholar
• Shatin D, Schech SD, Patel K, McHutchison JG. Population-based hepatitis C surveillance and treatment in a national managed care organization. Am J Manag Care 2004;10:250–256
   PubMed Web of Science ®Google Scholar
• Kanwal F, Hoang T, Spiegel BM, Eisen S, Dominitz JA, Gifford A, et al. Predictors of treatment in patients with chronic hepatitis C infection – role of patient versus nonpatient factors. Hepatology 2007;46:1741–1749
   PubMedGoogle Scholar
• Feuerstadt P, Bunim AL, Garcia H, Karlitz JJ, Massoumi H, Thosani AJ, et al. Effectiveness of hepatitis C treatment with pegylated interferon and ribavirin in urban minority patients. Hepatology 2010;51:1137–1143
   PubMed Web of Science ®Google Scholar